Antegrade perfusion with bacillus calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: Who may benefit?

European Urology

Volumn 60, Issue 5, 2011, Pages 955-960

  Giannarini, Gianluca ^a   Kessler, Thomas M ^a   Birkhäuser, Frédéric D ^a   Thalmann, George N ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacillus Calmette Gu rin; Follow up studies; Upper urinary tract; Urothelial carcinoma

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CARCINOMA IN SITU; DISEASE FREE SURVIVAL; ESCHERICHIA COLI INFECTION; FOLLOW UP; GRAM NEGATIVE SEPSIS; HUMAN; MAJOR CLINICAL STUDY; NEPHROURETERECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UPPER URINARY TRACT NON MUSCLE INVASIVE UROTHELIUM CARCINOMA; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BCG VACCINE; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; PERFUSION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME; UROLOGIC NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 80053313590     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.07.051     Document Type: Article

References (18)

1. M. Rouprêt, R. Zigeuner, and J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594
2. J.P. O'Donoghue, and J.P. Crew Adjuvant topical treatment of upper urinary tract urothelial tumours BJU Int 94 2004 483 485 (Pubitemid 39256464)
3. U.E. Studer, G. Casanova, R. Kraft, and E.J. Zingg Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ J Urol 142 1989 975 977 (Pubitemid 19250744)
4. G.N. Thalmann, R. Markwalder, B. Walter, and U.E. Studer Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery J Urol 168 2002 1381 1385 (Pubitemid 35034127)
5. Common Terminology Criteria for Adverse Events v.4.0. National Cancer Institute Web site. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14- QuickReference-5x7.pdf. Accessed May 20, 2011.
6. H.W. Herr Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin J Urol 134 1985 531 532 (Pubitemid 16236394)
7. A.D. Smith, E. Orihuela, and A.R. Crowley Percutaneous management of renal pelvic tumors: a treatment option in selected cases J Urol 137 1987 852 856 (Pubitemid 17074875)
8. J.R. Sharpe, G. Duffy, and J.L. Chin Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ J Urol 149 1993 457 460 (Pubitemid 23094029)
9. H. Yokogi, Y. Wada, M. Mizutani, M. Igawa, and T. Ishibe Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract Br J Urol 77 1996 676 679
10. Y. Nishino, N. Yamamoto, H. Komeda, Y. Takahashi, and T. Deguchi Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract BJU Int 85 2000 799 801 (Pubitemid 30242780)
11. N. Nonomura, Y. Ono, and M. Nozawa Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma on situ of the upper urinary tract Eur Urol 38 2000 701 705
12. K. Okubo, K. Ichioka, N. Terada, Y. Matsuta, K. Yoshimura, and Y. Arai Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure BJU Int 88 2001 343 347 (Pubitemid 34066069)
13. A. Irie, M. Iwamura, K. Kadowaki, A. Ohkawa, T. Uchida, and S. Baba Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter Urology 59 2002 53 57 (Pubitemid 34059307)
14. H. Miyake, H. Eto, S. Hara, H. Okada, S. Kamidono, and I. Hara Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract Int J Urol 9 2002 677 680
15. Y. Hayashida, K. Nomata, and M. Noguchi Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract Urology 63 2004 1084 1088 (Pubitemid 38746808)
16. Y. Kojima, K. Tozawa, N. Kawai, S. Sasaki, Y. Hayashi, and K. Kohri Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy Int J Urol 13 2006 340 344 (Pubitemid 43827981)
17. A.R. Rastinehad, and A.D. Smith Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role? J Endourol 23 2009 563 568
18. A.R. Rastinehad, M.C. Ost, and B.A. Vanderbrink A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? Urology 73 2009 27 31